ECSP003446A - COMBINATION THERAPY FOR HCV - Google Patents
COMBINATION THERAPY FOR HCVInfo
- Publication number
- ECSP003446A ECSP003446A ECSP003446A ECSP003446A EC SP003446 A ECSP003446 A EC SP003446A EC SP003446 A ECSP003446 A EC SP003446A EC SP003446 A ECSP003446 A EC SP003446A
- Authority
- EC
- Ecuador
- Prior art keywords
- combination therapy
- hcv
- effective amount
- therapeutically effective
- period sufficient
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title abstract 2
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 208000020403 chronic hepatitis C virus infection Diseases 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960000329 ribavirin Drugs 0.000 abstract 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se decsriben los métodos para tratar pacientes que tienen infecciones virales susceptibles, especialmente la infección por hepatitis C crónica administrando a dicho paciente una cantidad terapéuticamente efectiva de una terapia de combinación de interferón-alfa y ravabirina durante un periodo suficiente como para bajar el VHC-ARN asociado con una cantidad terapéuticamente efectiva de un antioxidante durante un periodo suficiente como para mejorar la hemólisis relacionada con la ribavirina.Methods of treating patients who have susceptible viral infections, especially chronic hepatitis C infection, are described by administering to that patient a therapeutically effective amount of a combination therapy with interferon-alpha and ravabirin for a period sufficient to lower HCV-RNA associated with a therapeutically effective amount of an antioxidant for a period sufficient to improve ribavirin-related hemolysis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003446 ECSP003446A (en) | 2000-04-27 | 2000-04-27 | COMBINATION THERAPY FOR HCV |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003446 ECSP003446A (en) | 2000-04-27 | 2000-04-27 | COMBINATION THERAPY FOR HCV |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003446A true ECSP003446A (en) | 2000-11-24 |
Family
ID=42041074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003446 ECSP003446A (en) | 2000-04-27 | 2000-04-27 | COMBINATION THERAPY FOR HCV |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003446A (en) |
-
2000
- 2000-04-27 EC ECSP003446 patent/ECSP003446A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR023541A1 (en) | HCV COMBINATION THERAPY | |
| WO2000037110A3 (en) | Ribavirin-pegylated interferon alfa induction hcv combination therapy | |
| DK1173178T3 (en) | Composition comprising apomorphine and sildenafil and its use in the treatment of erectile dysfunction | |
| DK1267897T3 (en) | Treatment of congestive heart failure with pretreated autologous blood | |
| AR019551A1 (en) | USE OF RIBAVIRINE IN COMBINATION WITH INTERFERON ALFA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR COMBINATION THERAPY TO ERADICATE HCV-RNA DETECTABLE IN PATIENTS NOT AFFECTED TO ANTIVIRAL TREATMENT THAT HAVE INFECTION OF CHRONIC HEPATITIS C | |
| BR9809425A (en) | Alpha interferon-polyethylene glycol conjugates for infection therapy | |
| DK1658302T3 (en) | Purine nucleoside analogues for the treatment of diseases caused by Flavirividae, including hepatitis C | |
| AR023824A1 (en) | HIV THERAPY COMBINATION OF ANTAGONIST CCR5-INTERFERON ALFA PEGILADO. | |
| CO6220969A2 (en) | WEEKLY ADMINSITRATION OF DIPEPTIDILO PEPTIDASE INHIBITORS | |
| NO20034878D0 (en) | Antiviral compounds | |
| AR025449A1 (en) | PHARMACEUTICAL SOLUTIONS OF LEVOSIMENDAN | |
| TW200633995A (en) | Andrographolide derivatives to treat viral infections | |
| NZ588655A (en) | Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin | |
| PE20001386A1 (en) | COMBINATION THERAPY FOR HCV BY INDUCTION OF RIBAVIRIN-INTERFERON ALPHA | |
| MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
| AR036697A1 (en) | METHOD FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITHOUT TREATMENT RESPONSE | |
| DE60204694D1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE | |
| CO5170412A1 (en) | TREATMENT OF RENAL CELL CARCINOMA | |
| CO5160259A1 (en) | INTERFERON ALFA PEGILADO IN THE THERAPY AGAINST HIV | |
| WO2005058237A3 (en) | Treatment of aids | |
| NO20055512L (en) | Therapy or prevention of respiratory viral infections with alpha-thymosin peptides | |
| FI954127A0 (en) | A method for treating hepatitis C in patients who do not respond to interferon therapy | |
| CY1106388T1 (en) | THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN | |
| EA199800770A1 (en) | DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS | |
| DK1150981T3 (en) | Therapeutic necleoside compound |